PT Organon Pharma Indonesia Tbk(ID:SCPI)
ID:SCPI
PT Organon Pharma Indonesia Tbk stock analysis
PT Organon Pharma Indonesia Tbk (SCPI) Stock Price & Analysis
SCPI Stock Chart & Stats
No data to display
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- N/A
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- N/A
- Next Earnings
- Apr 06, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Dec 01, 2023
- Dividend Yield
- N/A
SCPI FAQ
When is PT Organon Pharma Indonesia Tbk’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PT Organon Pharma Indonesia Tbk’s earnings last quarter?
PT Organon Pharma Indonesia Tbk released its earnings results on Jul 30, 2026. The company reported Rp24,056.21 earnings per share for the quarter.
Is PT Organon Pharma Indonesia Tbk overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PT Organon Pharma Indonesia Tbk pay dividends?
PT Organon Pharma Indonesia Tbk pays a dividend of Rp42,000 which represents an annual dividend yield of ―. See more information on PT Organon Pharma Indonesia Tbk dividends here
What is PT Organon Pharma Indonesia Tbk’s EPS estimate?
PT Organon Pharma Indonesia Tbk’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PT Organon Pharma Indonesia Tbk have?
PT Organon Pharma Indonesia Tbk has 3,600,000 shares outstanding.
What happened to PT Organon Pharma Indonesia Tbk’s price movement after its last earnings report?
PT Organon Pharma Indonesia Tbk reported an EPS of Rp24,056.21 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of PT Organon Pharma Indonesia Tbk?
Currently, no hedge funds are holding shares in ID:SCPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
